NDLEA DISMANTLES ABUJA DRUG BUNKS, ARRESTS 132, RECOVERS 220KG ILLICIT SUBSTANCES. (PHOTOS). #PRESS RELEASE.

-
Image
 NDLEA dismantles Abuja drug bunks, arrests 132, recovers 220kg illicit substances  -Marwa hails operation, vows to sustain crackdown in FCT, other states  In a non-stop two-week offensive action against traffickers and dealers, operatives of the National Drug Law Enforcement Agency (NDLEA) have successfully dismantled several drug joints and bunks within and around the Federal Capital Territory (FCT) Abuja where a total of 132 suspects were arrested and 220 kilograms of assorted illicit substances recovered. The wel-coordinated raids jointly conducted by the Agency's Directorate of Operations and General Investigation (DOGI) and the FCT Strategic Command from llth to 25th April 2026 were launched to dismantle illicit drug hubs contributing to substance abuse, trafficking, and associated criminal activities in the capital city after weeks of intelligence and surveillance across all identified hotspots. Areas where notorious drug joints were raided, dismantled and suspects...
Post a Comment

ZIMBABWE ROLLS OUT NEW HIV PREVENTION DRUG LENACAPAVIR. (PHOTO)

-


 Zimbabwe rolls out new HIV prevention drug lenacapavir


Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections.


Health Minister Douglas Mombeshora said the programme, funded by the U.S. and the Global Fund, would initially target more than 46,000 people at high risk of contracting HIV across 24 sites nationwide.


"Today marks an important day in Zimbabwe's national response to HIV. We gather here to launch lenacapavir - a long-acting injectable option for HIV prevention - and to show our commitment to protecting life and ending AIDS as a public health threat," Mombeshora said, Reuters reported.


He said Zimbabwe received its first batch and injected some early adopters earlier this month, adding that the rollout would be done in phases.


Significant progress


Lenacapavir, developed by Gilead Sciences, is administered as a subcutaneous injection twice a year. Officials say it could help overcome adherence challenges associated with daily oral pre-exposure prophylaxis (PrEP) pills.


Zimbabwe has made significant progress in tackling HIV, achieving the 95-95-95 treatment targets set by U.N. programme UNAIDS — meaning 95% of people living with HIV know their status, 95% of those diagnosed are on treatment, and 95% of those on treatment have suppressed viral loads.


Melody Dengu, a community leader in the Harare suburb of Epworth, said she had already received the jab earlier this month.


"I have also (so far) gotten 12 other people to come and get injected," she told Reuters at the event.


Zimbabwe has one of Africa's highest HIV burdens, though new infections have declined significantly over the past decade due to expanded testing, treatment and prevention.

Comments

Post a Comment